1. Home
  2. VERU vs ALOT Comparison

VERU vs ALOT Comparison

Compare VERU & ALOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • ALOT
  • Stock Information
  • Founded
  • VERU 1971
  • ALOT 1969
  • Country
  • VERU United States
  • ALOT United States
  • Employees
  • VERU N/A
  • ALOT N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • ALOT Computer peripheral equipment
  • Sector
  • VERU Health Care
  • ALOT Technology
  • Exchange
  • VERU Nasdaq
  • ALOT Nasdaq
  • Market Cap
  • VERU 85.5M
  • ALOT 69.2M
  • IPO Year
  • VERU 1990
  • ALOT N/A
  • Fundamental
  • Price
  • VERU $3.60
  • ALOT $11.05
  • Analyst Decision
  • VERU Strong Buy
  • ALOT
  • Analyst Count
  • VERU 3
  • ALOT 0
  • Target Price
  • VERU $33.33
  • ALOT N/A
  • AVG Volume (30 Days)
  • VERU 227.6K
  • ALOT 3.3K
  • Earning Date
  • VERU 08-12-2025
  • ALOT 09-15-2025
  • Dividend Yield
  • VERU N/A
  • ALOT N/A
  • EPS Growth
  • VERU N/A
  • ALOT N/A
  • EPS
  • VERU N/A
  • ALOT N/A
  • Revenue
  • VERU $16,886,419.00
  • ALOT $156,030,000.00
  • Revenue This Year
  • VERU N/A
  • ALOT N/A
  • Revenue Next Year
  • VERU N/A
  • ALOT N/A
  • P/E Ratio
  • VERU N/A
  • ALOT N/A
  • Revenue Growth
  • VERU 337.24
  • ALOT 7.14
  • 52 Week Low
  • VERU $2.64
  • ALOT $7.53
  • 52 Week High
  • VERU $14.20
  • ALOT $17.24
  • Technical
  • Relative Strength Index (RSI)
  • VERU 35.24
  • ALOT 46.92
  • Support Level
  • VERU $2.64
  • ALOT $11.04
  • Resistance Level
  • VERU $3.69
  • ALOT $11.65
  • Average True Range (ATR)
  • VERU 0.39
  • ALOT 0.50
  • MACD
  • VERU 0.02
  • ALOT -0.08
  • Stochastic Oscillator
  • VERU 40.27
  • ALOT 21.01

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About ALOT AstroNova Inc.

AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.

Share on Social Networks: